nontharit voravuth, eng wee chua, tuan mazlelaa tuan mahmood, ming chiang lim, sharifa ezat wan puteh, nik shanita safii, jyh eiin wong, ahmad taufik jamil, jamia azdina jamal, ahmad fuad shamsuddin, adliah mhd ali.  (2022).  engaging community pharmacists to eliminate inadvertent doping in sports: a study of their knowledge on doping.  - plos one.  1-14. 

muhammad asyaari zakaria, jazli aziz, nor fadilah rajab, eng wee chua and siti fathiah masre.  (2022).  tissue rigidity increased during carcinogenesis of ntcu-induced lung squamous cell carcinoma in vivo.  - biomedicines.  1-16. 

nuraziemah ahmad, chua eng wee, lam kok wai, noraziah mohamad zin, fazren azmi.  (2021).  biomimetic amphiphilic chitosan nanoparticles: synthesis, characterization and antimicrobial activity.  - carbohydrate polymers.  1-8. 

amnani aminuddin, pei yuen ng, chee-onn leong, eng wee chua.  (2021).  author correction: mitochondrial dna alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma.  - scientific reports.  1-3. 

muhammad asyaari zakaria, nor fadilah rajab, eng wee chua, gayathri thevi selvarajah, siti fathiah masre.  (2021).  roles of rho associated kinase in lung cancer: review.  - international journal of oncology.  185-198. 

poh kuan wong, fook choe cheah, saiful effendi syafruddin, m aiman mohtar, norazrina azmi, pei yuen ng, eng wee chua.  (2021).  crispr gene-editing models geared toward therapy for hereditary and developmental neurological disorders.  - frontiers in pediatrics.  1-15. 

muhammadasyaari zakaria, nor fadilah rajab, eng wee chua, gayathrithevi selvarajah & siti fathiah masre.  (2021).  ntcu induced pre-malignant and malignant stages of lung squamous cell carcinoma in mice model.  - scientific reports.  1-10. 

amnani aminuddin, pei yuen ng, chee onn leong, eng wee chua.  (2020).  mitochondrial dna alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma.  - scientific reports.  1-17. 

simone l. cree, eng wee chua, jennifer crowther, renwick c.j. dobson, martin a. kennedy.  (2020).  g-quadruplex structures bind to ez-tn5 transposase.  - biochimie.  190-197. 

eng wee chua, simon p. harger, martin a. kennedy.  (2019).  metoclopramide-induced acute dystonic reactions may be associated with the cyp2d6 poor metaboliser status and pregnancy-related hormonal changes.  - frontiers in pharmacology.  1-5. 

sheng zhang lim, eng wee chua.  (2018).  revisiting the role of thiopurines in inflammatory bowel disease through pharmacogenomics and use of novel methods for therapeutic drug monitoring.  - frontiers in pharmacology.  . 

chua eng wee, ng pei yuen.  (2016).  minion: a novel tool for predicting drug hypersensitivity?.  - frontiers in pharmacology.  1-7. 

eng wee chua, simone l. cree, kim n. t. ton, klaus lehnert, phillip shepherd, nuala helsby, martin a. kennedy.  (2016).  cross-comparison of exome analysis, next-generation sequencing of amplicons, and the iplex adme pgx panel for pharmacogenomic profiling.  - frontiers in pharmacology.  1-7. 

eng wee chua, simone cree, murray l. barclay, kit doudney, alan aitchison, martin a. kennedy.  (2015).  exome sequencing and array-based comparative genomic hybridisation analysis of preferential 6-methylmercaptopurine producers.  - the pharmacogenomics journal.  414-421. 

eng wee chua, allison l. miller, martin a. kennedy.  (2015).  choice of pcr microtube can impact on the success of long-range pcrs.  - analytical biochemistry.  115-117. 

trent, r.j., cheong, p.l., chua, e.w., kennedy, m.a..  (2013).  progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.  - pathology.  45(4):357-370. 

eng wee chua, james foulds, allison l. miller, martin a. kennedy.  (2013).  novel cyp2d6 and cyp2c19 variants identified in a patient with adverse reactions towards venlafaxine monotherapy and dual therapy with nortriptyline and fluoxetine.  - pharmacogenetics and genomics.  494-497.